MLCAC.PA Lombard & Medot (EURONEXT) down 9.62% intraday 23 Feb 2026: monitor €14.10 support
The MLCAC.PA stock tumbled 9.62% intraday on EURONEXT to €14.10 on 23 Feb 2026, making it one of Europe’s top losers in the Consumer Defensive sector. The drop follows an early open at €16.40 and a day high of €16.40, confirming heavy profit-taking. Volume is light at 6.00 shares traded, but the move widened the gap versus the 50-day average €14.55. We assess valuation, technical support, and Meyka AI forecasts to show where Lombard & Medot SA may trade next and which risks to monitor
MLCAC.PA stock: Intraday price action and context
MLCAC.PA stock fell to €14.10 today, down -9.62% from the previous close of €15.60. The shares opened at €16.40 and traded between a low of €14.10 and a high of €16.40. Volume was just 6.00 versus an average volume of 5.00, so price moves are exaggerated by thin liquidity.
This intraday decline places the share near the year high of €16.80 and well above the year low of €12.70, which frames a short-term trading range for intraday sellers.
MLCAC.PA stock: Valuation versus Consumer Defensive peers
Lombard & Medot SA shows a price to book ratio of 0.50 and a price to sales ratio of 0.61, which look inexpensive versus larger consumer peers. The reported PE from the quote is 100.71, while trailing metrics in the dataset show higher variability; this reflects very low EPS of €0.14 per share.
Compare this to the Consumer Defensive sector average PE of 24.21. The gap suggests investors price MLCAC.PA for uneven earnings, and small shifts in net profit would swing the PE dramatically.
MLCAC.PA stock: Fundamentals and balance sheet highlights
Key balance-sheet metrics show strong book value per share at €28.23 and shareholders’ equity per share at €28.23. Current ratio is 7.44, implying short-term liquidity comfort. Net debt to EBITDA is elevated at 14.66, which signals leverage pressure relative to cash generation.
Net profit margin is tiny at 0.08% and return on equity is near 0.06%, underlining low profitability despite healthy asset coverage. These fundamentals explain why earnings changes drive large price moves in this thinly traded stock.
MLCAC.PA stock: Technicals, support and resistance levels
Momentum indicators are mixed: RSI is 46.59, MACD histogram is 0.03, and ADX is 24.29, showing no strong trend yet. Bollinger Bands sit at €12.79–€16.33, with the middle band at €14.56, and today’s close at €14.10 tests the lower-middle band.
Immediate support is the day low €14.10 and structural support near the 50-day average €14.55. Resistance to watch is €16.40 and the year high €16.80. Traders should note the very low average volume, which raises volatility risk.
MLCAC.PA stock: Meyka grade, analyst view and forecast
Meyka AI rates MLCAC.PA with a score out of 100: 63.40 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are informational and not financial advice.
Meyka AI’s forecast model projects a yearly price of €15.17, a three-year price of €15.44, and a monthly spike to €21.08 under scenario-driven inputs. The yearly forecast implies an upside of 7.59% versus the current €14.10. Forecasts are model-based projections and not guarantees.
MLCAC.PA stock: Risks, catalysts and trading considerations
Key risks include very low liquidity, which can amplify moves from small orders, and a thin net profit margin that makes EPS volatile. High net debt to EBITDA increases sensitivity to weaker sales or cost shocks.
Potential catalysts are seasonal demand for champagne, export recoveries, and any company updates on margins or debt reduction. Given thin trading, use tight stop-losses and position sizing when trading MLCAC.PA stock on EURONEXT.
Final Thoughts
MLCAC.PA stock is an intraday top loser on EURONEXT after a -9.62% drop to €14.10 on 23 Feb 2026, driven by thin liquidity and profit-taking after an €16.40 open. Valuation shows a low price-to-book 0.50 but a high quoted PE 100.71, a mismatch caused by small EPS of €0.14. Technicals place immediate support at €14.10 and resistance near €16.40. Meyka AI’s forecast model projects a yearly price of €15.17, implying 7.59% upside from today’s price, but forecasts are model-based and not guaranteed. Our Meyka grade is 63.40 (B, HOLD) and balances decent balance-sheet cover against leverage and low profitability. For intraday traders, watch volume and plan exits; for longer-term investors, seek clearer earnings improvement or debt reduction before increasing exposure
FAQs
What caused MLCAC.PA stock to drop today?
The intraday drop to €14.10 reflects thin trading, profit-taking after a €16.40 open, and sensitivity to EPS swings given low liquidity. No major company announcement was posted during the session.
Is MLCAC.PA stock cheap compared with peers?
Price-to-book at 0.50 and P/S at 0.61 look cheap, but the quoted PE near 100.71 reflects very low EPS. Compare cautiously to sector PE of 24.21 because profitability is much weaker.
What is Meyka AI’s view and forecast for MLCAC.PA stock?
Meyka AI rates MLCAC.PA 63.40 (B, HOLD). The model projects a yearly price of €15.17, implying about 7.59% upside versus €14.10. Forecasts are model-based projections and not guarantees.
What are the key levels to watch for traders?
Watch immediate support at €14.10 and the 50-day average near €14.55. Key resistance sits at €16.40 and the year high €16.80. Monitor volume closely due to thin liquidity.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.